| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/06/2006 | US20060148792 Substituted 1,4-benzodiazepines and uses thereof |
| 07/06/2006 | US20060148791 Glutamate receptor antagonists |
| 07/06/2006 | US20060148769 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 07/06/2006 | US20060148751 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 07/06/2006 | US20060148732 Inhibition of NF-kappaB by triterpene compositions |
| 07/06/2006 | US20060147500 Use of isomalt (mixture of 1,6 gps and 1,1 gpm) as a prebiotic for the production of a medicament used for the treatment of intestinal diseases, among other things |
| 07/06/2006 | US20060147496 Diagnosis of irritable bowel disorders; fibromyalgia; chronic fatique syndrome; antidepressants; tinnitus; autism; autoimmune disease; Crohn's disease; quantitative analysis of serotonine, bile acid in sample |
| 07/06/2006 | US20060147446 Humanized antibodies to human GP39, compositions, and therapeutic uses thereof |
| 07/06/2006 | US20060147437 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/06/2006 | US20060147392 Agent for dissolving dental calculi and dental caries |
| 07/06/2006 | CA2594155A1 A process for producing a food or beverage |
| 07/06/2006 | CA2592532A1 Sesamin/episesamin compositions with improved bioavailability |
| 07/06/2006 | CA2592461A1 Drugs for diseases accompanying changes in total bile acid pool or lipid metabolism disorders and method of screening these drugs |
| 07/06/2006 | CA2592184A1 Oral compositions containing oxidized camellia |
| 07/06/2006 | CA2592122A1 Oral care composition containing extract of unoxidized camellia |
| 07/06/2006 | CA2591912A1 Pyrimidinylisoxazole derivatives |
| 07/06/2006 | CA2590681A1 N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid cb1 receptor antagonists |
| 07/06/2006 | CA2587793A1 Compositions for hcv treatment |
| 07/06/2006 | CA2587586A1 Compounds for flaviviridae treatment |
| 07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
| 07/05/2006 | EP1676585A1 Pepsin inhibition by alginates |
| 07/05/2006 | EP1676583A2 Therapeutic agent for periodontal disease |
| 07/05/2006 | EP1676580A1 Glycyrrhizin high-concentration preparation |
| 07/05/2006 | EP1675617A1 Compositions and methods for augmenting kidney function |
| 07/05/2006 | EP1675547A2 Glucocerebroside treatment of disease |
| 07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/05/2006 | EP1390049B1 Compositions for treating animal diseases and syndromes comprising transfer factor |
| 07/05/2006 | EP1389044A4 Ppar-alpha-gamma ligands or agonists for the treatment of inflammation |
| 07/05/2006 | EP1313739B1 Alkylated imidazopyridine derivatives |
| 07/05/2006 | EP1225894B1 Fab i inhibitors |
| 07/05/2006 | EP1139755B9 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 07/05/2006 | EP1039905B1 Pharmaceutical formulation comprising glycine as a stabilizer |
| 07/05/2006 | EP0733109B9 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 07/05/2006 | CN1798831A Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains |
| 07/05/2006 | CN1798746A Reverse-turn mimetics and method relating thereto |
| 07/05/2006 | CN1796540A Bifidobacterium possessing characteristic for anti pathogenesis bacterium in intestinal tract and antioxidation, and application |
| 07/05/2006 | CN1796533A Health protection wine and preparation method |
| 07/05/2006 | CN1796393A Analogue of nucleotide |
| 07/05/2006 | CN1796388A Sesamin/episesamin compositions |
| 07/05/2006 | CN1796381A Compound for treating B type hepatitis and medication composition |
| 07/05/2006 | CN1795923A Medication composition for treating chronic ulcerative colitis, and preparation method |
| 07/05/2006 | CN1795921A Medication for treating hepatic disease |
| 07/05/2006 | CN1795918A Medication for treating hepatitis B, preparation and taking method |
| 07/05/2006 | CN1795915A Medication for regulating qi and cultivating the mentality, and prepartion method |
| 07/05/2006 | CN1795914A Composition for treating throat oral disease, preparation and preparing method |
| 07/05/2006 | CN1795913A Medicament drop pills for nourish qi and yin, recovering channels and vessels, and increasing the body fluid, and preparation method |
| 07/05/2006 | CN1795902A Suppository of Chinese traditional medicine for improving intestine motivity and preparation method |
| 07/05/2006 | CN1795901A Medication for removing toxic heat, eliminating wetness and treating jaundice |
| 07/05/2006 | CN1795900A Soft capsule of acetic acid of hawkthorn, and preparation method |
| 07/05/2006 | CN1795896A Medication for curing hepatic fibrosis and hepatic cirrhosis, and prepartion method |
| 07/05/2006 | CN1795893A Medication composition for treating hepatitis, prepartion method and application |
| 07/05/2006 | CN1795883A A recipe of Chinese traditional medicine (shení»er capsule) |
| 07/05/2006 | CN1795871A Powder of Chinese traditional medicine and Western medicine |
| 07/05/2006 | CN1795865A Soft capsule of pentacycle triterpene composition possessing activity for nourish the liver |
| 07/05/2006 | CN1795858A Oral taking tablets of Roxatidine Acetate Hydrochloride |
| 07/05/2006 | CN1795856A Medicinal preparation of containing Tenatoprazole and preparation method |
| 07/05/2006 | CN1795849A Injection prescription of freeze-drying powder of ranitidine hydrochloric acid and preparation method |
| 07/05/2006 | CN1795736A Quick dissolving roselle tea bag |
| 07/05/2006 | CN1262636C Technology of producing high alcohol content nutritive wine using wolfberry and date as raw material |
| 07/05/2006 | CN1262548C Synthesis of benzoxazine monohydrochlorate compound |
| 07/05/2006 | CN1262541C Tricyclic protein kinase inhibitors |
| 07/05/2006 | CN1262308C Use of enzymes obtained from ciliates as medicaments for promoting digestion |
| 07/05/2006 | CN1262297C Chinese medicine for treating irritable bowel syndrome and preparing method thereof |
| 07/05/2006 | CN1262294C Ginseng and aconite injection liquid for treating qi vacuity and yang desertion and its preparation method |
| 07/05/2006 | CN1262293C Ginseng and aconite preparation for treating qi vacuity yang desertion and its extraction method |
| 07/05/2006 | CN1262290C Oral liquid for biliary track ascariasis |
| 07/05/2006 | CN1262281C Drugs, foods, drinks and feeds containing cocoa component |
| 07/05/2006 | CN1262278C Antiacid and laxative tablets |
| 07/05/2006 | CN1262276C Health caring food for relieving constipation physically |
| 07/05/2006 | CN1262213C Water containing soluble fiber |
| 07/04/2006 | USRE39155 Administering cis configuration of 4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one; stereospecific; viral diseases |
| 07/04/2006 | US7071335 2-pyridinyl-1-piperazine therapeutic agents useful for treating pain |
| 07/04/2006 | US7071234 Administering racemic or optically pure sibutramine metabolite, or a pharmaceutically acceptable salt, solvate, or clathrate for prophylaxis or therapy |
| 07/04/2006 | US7071221 Heterocyclic oxime compounds |
| 07/04/2006 | US7071213 Cannabinoid receptor ligands |
| 07/04/2006 | US7071202 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 07/04/2006 | US7071196 Piperazine derivatives as antagonists of tachykinins, including substance P and other neurokinins. |
| 07/04/2006 | US7071193 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 07/04/2006 | US7071185 Treating schizophrenia with no weight-gain side effects; 5-HT2c recptor agonist; bipolar disorder; antidepressants; anxiolytic agents; panic attack; agoraphobia; antiepileptic agents; sleep disorders; migraines; sexual dysfunction |
| 07/04/2006 | US7071184 Protease inhibitors |
| 07/04/2006 | US7071170 Bactericides; antiprotozoa agents |
| 07/04/2006 | US7071160 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070814 Plant extracts for treatment of cancer |
| 07/04/2006 | US7070805 Comprises a pharmacologically active ingredient, a sugar and a low-substituted hydroxypropylcellulose having 5 to 7% by weight of hydroxypropyl group; fast disintegrability, suitable strength and no roughness |
| 07/04/2006 | CA2364719C 2-aminopyridines containing fused ring substituents |
| 07/04/2006 | CA2264721C A1 adenosine receptor antagonists |
| 07/04/2006 | CA2233285C Pyrazolopyrimidines as crf receptor antagonists |
| 07/04/2006 | CA2200579C Phenyl-oxo-alkyl-(4-piperidinyl)benzoate derivatives as colon motility enhancing agents |
| 06/29/2006 | WO2006069329A2 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis |
| 06/29/2006 | WO2006068485A2 Temporally meal menu for infants |
| 06/29/2006 | WO2006068213A1 Glycine derivative and use thereof |
| 06/29/2006 | WO2006068164A1 Tricyclic compound and use thereof |
| 06/29/2006 | WO2006068058A1 Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine |
| 06/29/2006 | WO2006067925A1 Hepatic function remedial agent |
| 06/29/2006 | WO2006067823A2 Pharmaceutical composition comprising nifedipine and mesalazine for the treatment of rectoanal tenesmus |
| 06/29/2006 | WO2006066924A2 Azole derivatives with antimuscarinic activity |
| 06/29/2006 | WO2006066746A1 Chroman derivatives and their use as 5-ht receptor ligands |
| 06/29/2006 | WO2006052889A3 Quinolinone-carboxamide compounds |
| 06/29/2006 | WO2006042950A3 Use of pyrrolopyrazine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells |